Carisma Therapeutics announced the appointment of Marella Thorell and David Scadden, M.D., to the Company’s Board of Directors, effective June 30, 2024. Additionally, Regina Hodits and Bjorn Odlander have informed the Board of their intention to step down as members effective June 30, 2024, due to other professional commitments.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CARM:
- Carisma Therapeutics nominates first candidate under collaboration with Moderna
- Carisma Therapeutics granted FDA Fast Track designation for CT-0525
- Carisma Therapeutics management to meet virtually with BTIG
- Carisma Therapeutics Grants Executive Stock Options for Retention
- Carisma Therapeutics: First patient dosed in Phase 1 clinical trial of CT-0525
Questions or Comments about the article? Write to editor@tipranks.com